Peter Hoang Insider Profile
4 Followers
Peter Hoang, President & CEO, Director at Marker Therapeutics, holds 483.29K shares in Marker Therapeutics (Ticker: MRKR), holds 0.00 shares in Bellicum Pharmaceuticals (Ticker: BLCM).
Peter Hoang's Trading History
| MRKRMarker Therapeutics | Mar 28, 2022 | President & CEO, Director | Uninformative Buy | ― | $420.46K | |
| BLCMBellicum Pharmaceuticals | ― | ― | ― | $0.00 |
You May Also Like
Peter Hoang insider profile FAQ
What is the percentage of profitable transactions made by Peter Hoang?
The percentage of profitable transactions made by Peter Hoang is 0%.
What is the average return per transaction made by Peter Hoang?
The average return per transaction made by Peter Hoang is -68.90%.
What stocks does Peter Hoang hold?
Peter Hoang holds: MRKR, BLCM stocks.
What was Peter Hoang's most profitable transaction?
Peter Hoang’s most profitable transaction was an Informative Buy of MRKR stock on August 15, 2019. The return on the trade was -62.00%.
What is Peter Hoang's role in Marker Therapeutics?
Peter Hoang's role in Marker Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
